SCHEMBL8864979

SCHEMBL8864979

CCC(CCCC1(N=S(=O)=O)CC1c1ccccc1)OC.CNC(=S)NC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8865047 0.94 — —
SCHEMBL8864457 0.91 FPR1 (0.30) —
SCHEMBL8864247 0.90 FPR1 (0.30) —
SCHEMBL8864331 0.88 FPR1 (0.31) —
SCHEMBL8864488 0.86 — —
SCHEMBL8864310 0.85 MEN1 (0.30) —
SCHEMBL8864292 0.80 SLC6A2 (0.32) —
SCHEMBL8864523 0.80 FPR1 (0.32) —
SCHEMBL8864383 0.78 — —
SCHEMBL8864415 0.75 SLC6A2 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5633239-A CARDIOVASCULAR DISORDERS; HYPOGLYCEMIC AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 1997-05-27 — — US disclosed
Send feedback